Meanwhile, glucose transporter 5 (Glut5, encoded by SLC2A5), a specific transporter of fructose, was found to be upregulated in these tumor cells, and its expression level was closely correlated with malignant evolution and clinical prognosis [12, 14, 15]. Here, SLC2A5 is linked to neoplasm.